GO/AgNW aided sustained release of ciprofloxacin loaded in Starch/PVA nanocomposite mats for wound dressings application

Compared to conventional bandages, which do not meet all wound care requirements, nanofiber wound dressings could provide a potentially excellent environment for healing. In the present research, nanocomposite membrane based on starch (St) - polyvinyl alcohol (PVA) nanofibers containing ciprofloxacin antibiotic drug loaded on graphene oxide‑silver nanowire (GO-AgNWs) hybrid nanoparticles is produced by electrospinning process. Morphological studies showed that the length and diameter of silver nanowires are 21 ± 9.17 μm and 82 ± 10.52 nm, respectively. The contact angle of 57.1° due to the hydrophilic nature of nanofibers, also the swelling degree of 679.51 % and, the water vapor permeability of 2627 ± 56 (g/m2.day) can be expressed as a confirmation of the ability of this wound dressing to manage secretions around the wound. In evaluating the antibacterial activity of these nanocomposite membranes against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus bacteria, the most potent antibacterial effect is in the case of nanofibers containing a high percentage of starch and nanoparticles carrying ciprofloxacin; with non-growth halos of 47.58 mm and 22.06 mm was recorded. The release of ciprofloxacin drug in vitro was reported to be 61.69 % during 24 h, and the final release rate was 82.17 %. Despite the biocompatibility and cell viability of 97.74 % and the biodegradability rate of 28.51 %, the StP-GOAgNWCip nanocomposite membrane can be introduced as a suitable candidate for wound dressing.